Medication Abortion in Jeopardy?
Gender Justice Legal Director Jess Braverman and Executive Director Megan Peterson discuss the Alliance Defending Freedom’s lawsuit against the FDA for its approval of Mifepristone over 20 years ago.
![The Gender Justice Brief Medication Abortion in Jeopardy?](https://www.genderjustice.us/wp-content/uploads/2023/02/podcast-medication-abortion-150x150.png)
Mifepristone is the first pill in the two-pill regimen that makes up medication abortion. If successful, the lawsuit could hinder access to medication abortion across the country. The Gender Justice team discusses how this ruling would affect Minnesota providers and patients, as well as new updates on reproductive freedom legislation advancing at the Minnesota legislature this session.
About The Gender Justice Brief
The Gender Justice Brief is produced by Gunther Michael Jahnl of IQONEQ Communications Solutions and Audra Grigus.
Visit Gender Justice and UnRestrict Minnesota.
Latest Episodes
- SCOTUS Chat: Supreme Court Punts Decision on Emergency Abortion Care Ahead of 2024 Election
- “Fostering joy and health”: Minnesota’s new gender-affirming care law
- SCOTUS Chat: Abortion Win with Troubling Implications
- Helping the helpers: a victory in the fight to fund abortions in Alabama
- Re-release for 10th anniversary of the Women’s Economic Security Act (WESA)
- SCOTUS Chat: Can States Ban Emergency Abortion Care?
- SCOTUS Chat: The Future of Medication Abortion Access
- Preconceived: Exposing Crisis Pregnancy Centers
- Another Victory for Abortion Rights in Minnesota
- Gender Equity in Minnesota: 2024 Legislative Agenda Briefing